Site Map

en

• Research Teams
  • Teams
    • Glycogenomics
      • Glycogenomics
      • Glycogenomic’s Team
      • CAZy
    • Medicinal Chemistry and Structural Virology
      • KA’s Team
      • Fragment-based drug discovery using the NS3 and NS5 flavivirus domains as targets
      • Development of new phosphonate nucleoside analogs to circumvent the resistance of HIV-1 RT against nucleotides.
      • Hit-to-Lead optimisation. Target : Dengue NS5 polymerase
      • Dinucleotides as potent inhibitors of the HCV NS5B Polymerase
      • Antiviral Medicinal Chemistry
    • Molecular Transport and Signalling
      • Molecular Transport and Signalling
      • The team
      • Bacterial secretion systems
      • Baseplates from phages infecting Gram⁺ bacteries and their fonction in infection
      • Proteins from crenarchaeal viruses
      • Transcription control by the Hox proteins
      • Insect olfaction proteins
    • Structural disorder and Molecular Recognition
      • Molecular partnership of the intrinsically disorder C-terminal domain of the measles virus nucleoprotein (NTAIL)
      • SL’s Team
      • Structural disorder and molecular partnership of intrinsically disordered regions of the nucleoproteins and phosphoproteins of Henipaviruses
      • SL’s Team publications
      • Molecular bases of specificity and affinity in partner recognition by intrinsically disordered proteins (IDPs)
      • Development of MeDor, a metaserver for the prediction of protein disorder
      • Structural disorder and Molecular Recognition
    • Structural Glycobiology and Neurobiology
      • Structural Glycobiology and Neurobiology
      • Team composition
    • Structural Immunology
      • Structural Immunology
      • Molecular mechanism of activation of the Drosophila Toll receptor
      • AR’s Team
      • Activation and regulation of the Drosophila Imd and JAK/STAT pathways
      • Study of the TSSP protease and its role in the diabete
    • Viral Replicases : Structure, Mechanism and Drug-Design
      • Viral Replicases : Structure, Mechanism and Drug-Design
      • Study of RNA-dependent RNA polymerases
      • Studies of RNA capping enzymes
      • Studies of enzymes associated with the replication complex
      • Tools and multidisciplinary approaches
      • Production of recombinant proteins
      • Screening platform "PCML" and "AD2P"
      • BC’s Team
• The Laboratory
  • Organisational Chart
  • Lab members
  • Publications
  • AFMB
  • Communication
    • Legal Informations
    • Practical Course on High Throughput Recombinant Protein Production for Protein-Protein and Protein-Nucleic Acid Complexes
    • Special Interest Group in Macromolecular Crystallography
      • Current SIG1 Officers
      • SIG1 Contact
      • Individual Members of the ECA interested in SIG1 activities
      • SIG1 Activities
      • Sig1 2009 Annual Report
  • Staff
    • Pascale Marchot, "Structural Glycobiology and Neurobiology" team
• Facilities
  • Cloning, expression, purification of recombinant proteins
  • Isothermal Titration Calorimetry
  • Multi-Angle Light Scattering coupled to Size-Exclusion Chromatography (MALS/SEC)
  • Screening Platform Marseille-Luminy (PCML)
  • Surface Plasmon Resonance
• News
  • Practical Course on High Throughput Recombinant Protein Production for Protein-Protein and Protein-Nucleic Acid Complexes
  • To Fold or to Refold? A Shakespearean question applied to recombinant proteins.
  • Weakening mRNA secondary structures at the Ribosome Binding Site (RBS) can improve protein expression yields in E. coli.